Search

everythinglearnresearchcommunity

for

Search:↓

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Microspheric skin organoids can be used for drug testing, identifying Minoxidil as a Wnt pathway activator.

Certain compounds can boost hair and nail growth.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Radiation damages salivary glands by harming blood vessels, but antioxidants might help protect them.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Some plants like spinach, broccoli, and matcha may boost the effectiveness of the hair growth drug minoxidil.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Five FDA-approved drugs may help block COVID-19 virus entry.

Minoxidil boosts hair growth by targeting adenosine and possibly sulfonylurea receptor 2B.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Gefitinib can cause hair loss without scarring.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.